| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2879126 | The Annals of Thoracic Surgery | 2010 | 5 Pages |
Abstract
The extremely poor prognosis of sarcomatoid malignant pleural mesothelioma is independent of the extent of surgery unlike other cell types. Patients with sarcomatoid histology should therefore be considered separately in trials evaluating radical procedures and adjuvant treatment. The treatment of biphasic pleural mesothelioma remains debatable.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Bram MD, Delphine MD, Apostolos MD, Antonio E. MD, John MD, PhD, David A. MD,